Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's disease

Raquel Pinheiro Barbosa1, Paulo Bastos1, Matthieu Béreau2

  • 1Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.

Abstract